UNSPSC 51343304: Mozenavir

This classification denotes a protease inhibitor with the molecular formula C33H36N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 64OO8946ER. The term MOZENAVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46. ). Most nations schedule mozenavir under HS 29339940 and SITC 51577. As of Q4 2014, MOZENAVIR remains the US FDA Preferred Term for this commodity. Mozenavir bears US NLM identifiers UMLS ID C0390428 and NCI Concept Code C77390.

SMILES: C1=CC=C(C=C1)CC2C(C(C(N(C(=O)N2CC3=CC(=CC=C3)N)CC4=CC(=CC=C4)N)CC5=CC=CC=C5)O)O.

UNSPSC 51343304 Mozenavir, a Commodity code, does not align with the state and local procurement activity tagged under it. The source contains no recent opportunities soliciting mozenavir specifically; instead, the four most recent opportunities tagged to this code span naloxone and safe drug deactivation systems, direct-to-manufacturer prescription programs, generic multi-source pharmaceuticals and OTC products, and emergency medical supplies. The mismatch suggests either a tagging error in the source data or that this code is being used as a catch-all for pharmaceutical and medical supply procurement more broadly rather than for mozenavir alone.

The issuing bodies in the recent opportunities include county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local governments in Minnesota and Oregon). Geographic activity spans Florida, Texas, and the upper Midwest. Representative opportunities include Seminole County's IFB for naloxone and drug deactivation systems with a response date of July 26, 2023 (a historical posting date that appears misaligned with the 2026 current date); the City of Tampa's IFB for medical and first aid supplies for the Fire Department Rescue Division, due March 13, 2026, with an estimated contract value of $700,000 and a 5 percent bid discount set-aside for certified Small Local Business Enterprises; and Minnesota's MMCAP RFP for generic pharmaceuticals and OTC products, with proposals due March 26, 2026. The code shows little relevant recent activity specific to mozenavir procurement.